Results 131 to 140 of about 148,565 (404)

Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation

Journal of cardiac surgery, 2020
Extracorporeal membrane oxygenation (ECMO) induces hemostatic alterations that may contribute to hematological complications. Unfractionated heparin (UFH) is the mainstay antithrombotic in ECMO and depends on antithrombin III (AT III) to exhibit its ...
H. Kaseer, M. Soto-Arenall, D. Sanghavi, J. Moss, Robert A. Ratzlaff, S. Pham, P. Guru   +6 more
semanticscholar   +1 more source

Extracorporeal membrane oxygenation (ECMO)

Southern African Journal of Critical Care, 2013
Extracorporeal membrane oxygenation (ECMO) is increasingly being employed in South African intensive care units for the management of patients with refractory hypoxaemia and for haemodynamic support, particularly following cardiothoracic procedures. ECMO is expensive, however, and there is a danger that this rescue modality may be abused or utilised ...
Ivan Joubert, Guy A. Richards
openaire   +4 more sources

Extracorporeal Membrane Oxygenation [PDF]

Critical Care Clinics, 2017
Nitin Puri, Nicholas C. Cavarocchi, Michael Baram   +2 more
openaire   +6 more sources

Early Albumin Administration in Veno-Arterial Extracorporeal Membrane Oxygenation. [PDF]

Artif Organs
A total of 660 patients received VA ECMO support (66.4% eCPR). Three different volume resuscitation strategies were employed. The Crystalloid group received balanced crystalloid volume substitution. In the Albumin group, a 1:4 volume mixture of albumin and balanced crystalloids (10 g/L) was used.
Wengenmayer T, Hirth ML, Jäckel M, Bemtgen X, Kaier K, Biever PM, Supady A, Maulhardt T, Westermann D, Staudacher DL, Rilinger J.   +10 more
europepmc   +2 more sources

Significant social events and increasing use of life-sustaining treatment: trend analysis using extracorporeal membrane oxygenation as an example [PDF]

, 2014
Background Most studies have examined the outcomes of patients supported by extracorporeal membrane oxygenation as a life-sustaining treatment.
Likwang Chen, Shan-Chwen Chang, Tien-Shang Huang, Tzong-Shinn Chu, Wen-Je Ko, Yen-Hsuan Ni, Yen-Yuan Chen   +6 more
core   +1 more source

Current and novel biomarkers in cardiogenic shock

European Journal of Heart Failure, EarlyView.
A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end‐organ dysfunction.
Victor Galusko, Florian A. Wenzl, Christophe Vandenbriele, Vasileios Panoulas, Thomas F. Lüscher, Diana A. Gorog   +5 more
wiley   +1 more source

Extracorporeal Membrane Oxygenation

DeckerMed Transitional Year Weekly Curriculum™, 2018
Extracorporeal membrane oxygenation (ECMO), also known as extracorporeal life support, is the practice of using circulatory assist devices and a gas exchange system to maintain sufficient tissue oxygen delivery, supplementing pulmonary and/or cardiac function in patients whose native physiology is too severely altered to be successfully supported ...
Joe L. Hsu, Richard Ha, Stephen Ruoss, Julian Villar   +3 more
openaire   +2 more sources

Effect of venoarterial extracorporeal membrane oxygenation initiation timing on tricuspid valve surgery outcomesCentral MessagePerspective

JTCVS Open, 2023
Objectives: Tricuspid valve surgery is associated with high rates of shock and in-hospital mortality. Early initiation of venoarterial extracorporeal membrane oxygenation after surgery may provide right ventricular support and improve survival.
Amy Hembree, BS, Matthew Lawlor, MD, Samantha Nemeth, MS, MA, MPH, Sivagowry Rasalingam Mørk, MD, PhD, Yuji Kaku, MD, Jessica Spellman, MD, Andrea Miltiades, MD, Paul Kurlansky, MD, Koji Takeda, MD, Isaac George, MD   +9 more
doaj  

What Should We Learn From Early Hemodialysis Allocation About How We Should Be Using ECMO? [PDF]

, 2019
Early hemodialysis allocation deliberations should inform our current considerations of what constitutes reasonable uses of extracorporeal membrane oxygenation.
bosslet, Gabriel T., Gutteridge, Daniel
core   +1 more source

Incidence and predictors of weaning failure from veno‐arterial extracorporeal membrane oxygenation therapy in patients with cardiogenic shock

European Journal of Heart Failure, EarlyView.
Predictors of weaning failure from veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) in patients with cardiogenic shock. RRT, renal replacement therapy. Abstract Aims This study aimed to investigate incidence and predictors of weaning failure and in‐hospital death after successful weaning from veno‐arterial extracorporeal membrane oxygenation
Angela Dettling, Caroline Kellner, Jonas Sundermeyer, Benedikt N. Beer, Lisa Besch, Letizia Fausta Bertoldi, Stefan Blankenberg, Jeroen Dauw, Dennis Eckner, Ingo Eitel, Tobias Graf, Patrick Horn, Joanna Jozwiak‐Nozdrzykowska, Paulus Kirchhof, Stefan Kluge, Jannis Krais, Dirk von Lewinski, Axel Linke, Peter Luedike, Enzo Lüsebrink, Peter Nordbeck, Federico Pappalardo, Matthias Pauschinger, Alastair Proudfoot, Tienush Rassaf, Hermann Reichenspurner, Can Martin Sag, Clemens Scherer, P. Christian Schulze, Robert H.G. Schwinger, Carsten Skurk, Marek Sramko, Guido Tavazzi, Holger Thiele, Nuccia Morici, Ephraim B. Winzer, Dirk Westermann, Benedikt Schrage, Norman Mangner   +38 more
wiley   +1 more source